Katharine Hsu

Katharine Hsu is a Professor at Weill Cornell Medical College and a Member of Immunology & Microbial Pathogenesis at the Weill Cornell Graduate School of Medical Sciences. She directs the Tri-Institutional MD-PhD Program and conducts translational research at Memorial Sloan Kettering Cancer Center (MSKCC), focusing on natural killer (NK) cells in cancer and viral immunity.

• Education: MD-PhD from Cornell University Medical College, undergraduate at Stanford University
• Clinical Expertise: Bone marrow transplantation, leukemia, lymphoma treatment

Her research explores:

• Genetic and molecular mechanisms of NK cell activation
• Role of KIR-HLA interactions in transplant outcomes
• CMV/HIV immune evasion strategies
• Metabolic regulation of NK function
• Development of NK-based therapies for neuroblastoma and leukemia

Key publications (2023-2021) reveal trends in

• Single-cell NK repertoire profiling
• CMV-induced immune adaptations
• IRF4-regulated nutrient uptake
• HLA-KIR genotype correlations
• Transplantation immunogenetics

Scientific distinctions include

• Induction into American Society for Clinical Investigation (2012)
• Leukemia & Lymphoma Society Scholar (2016)
• Weill Cornell Alumni Award of Distinction (2019)
• Membership in Association of American Physicians

As director of the Tri-Institutional MD-PhD Program, she emphasizes diversity in biomedical training while leading a translational research team at MSKCC that bridges clinical care and NK cell biology studies.